Evidence map›Paper›PMID 34302469›Full record

ArticleThe Journal of infectious diseases2021

Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.

Kristen K Bjorkman, Tassa K Saldi, Erika Lasda, Leisha Conners Bauer, Jennifer Kovarik, Patrick K Gonzales, Morgan R Fink, Kimngan L Tat, Cole R Hager, Jack C Davis and 6 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Modeling the Transmission Mitigation Impact of Testing for Infectious Diseases.medRxiv : the preprint server for health sciences · 2024
    Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant.Infectious disease clinics of North America · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Microorganisms · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. COVID-19 vaccination: Why extend the interval between doses?Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kristen K BjorkmanBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.ORCID 0000-0002-9540-6657
Tassa K SaldiBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Erika LasdaBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Leisha Conners BauerHealth Promotion, University of Colorado Boulder, Boulder, Colorado, USA.
Jennifer KovarikHealth Promotion, University of Colorado Boulder, Boulder, Colorado, USA.
Patrick K GonzalesBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Morgan R FinkBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Kimngan L TatBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Cole R HagerBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Jack C DavisBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Christopher D OzeroffBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Gloria R BrissonMedical Services, University of Colorado Boulder, Boulder, Colorado, USA.
Daniel B LarremoreBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Leslie A LeinwandBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Matthew B McQueenDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, USA.
Roy ParkerBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.

Funding

MYOSIN GENE DIVERSITY AND FUNCTIONR01GM029090 · NIGMS · YESHIVA UNIVERSITY · PI Leslie Anne Leinwand · 1985 to 2026
$12.3M
NIGMS NIH HHS R01 GM029090
6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 pandemic spread to >200 countries in <6 months. To understand coronavirus spread, determining transmission rate and defining factors that increase transmission risk are essential. Most cases are asymptomatic, but people with asymptomatic infection have viral loads indistinguishable from those in symptomatic people, and they do transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, asymptomatic cases are often undetected.

methodsGiven high residence hall student density, the University of Colorado Boulder established a mandatory weekly screening test program. We analyzed longitudinal data from 6408 students and identified 116 likely transmission events in which a second roommate tested positive within 14 days of the index roommate.

resultsAlthough the infection rate was lower in single-occupancy rooms (10%) than in multiple-occupancy rooms (19%), interroommate transmission occurred only about 20% of the time. Cases were usually asymptomatic at the time of detection. Notably, individuals who likely transmitted had an average viral load approximately 6.5-fold higher than individuals who did not (mean quantification cycle [Cq], 26.2 vs 28.9). Although students with diagnosed SARS-CoV-2 infection moved to isolation rooms, there was no difference in time to isolation between cases with or without interroommate transmission.

conclusionsThis analysis argues that interroommate transmission occurs infrequently in residence halls and provides strong correlative evidence that viral load is proportional to transmission probability.

Indexed as

Viral LoadAsymptomatic InfectionsCOVID-19HumansPandemicsSARS-CoV-2StudentsYoung Adultasymptomatic transmissionCOVID-19SARS-CoV-2viral load

Identifiers

PMID34302469
PMCPMC8861368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.